Skip to main content
Clinical Trials/JPRN-UMIN000033541
JPRN-UMIN000033541
Not yet recruiting
未知

The effect of SGLT2 inhibitor on diabetic cardiac autonomic neuropathy - The effect of SGLT2 inhibitor on diabetic cardiac autonomic neuropathy

Sakakibara Heart Institute0 sites200 target enrollmentJuly 28, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sakakibara Heart Institute
Enrollment
200
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) History of SGLT2 inhibitor treatment (2\) Associated with severe renal dysfunction (3\) Associated with respiratory disease (4\) History of cerebral infarction (5\) History of urinary / genital infection (6\) Women in pregnancy or at risk of becomming pregnant (7\) Breast\-feeding woment (8\) Patients whom researchers rule out as prropriate subjects

Outcomes

Primary Outcomes

Not specified

Similar Trials